Navigation Links
Percutaneous aortic valve replacement- a revolution in Cardiac Surgery

The aortic valve in the heart is the valve that governs the flow of blood into a large blood vessel namely the aorta, which supplies blood to various organs of the body. // It prevents the blood from flowing back inside the heart from the rest of the body.

The effective functioning of the heart depends on the proper functioning of the aortic valve. The aortic valve can be defective in some cases, leading to a compromise in the same. The defect can be present right form birth or it can be acquired as a result of other diseases.

This cardiac defect can be corrected by a surgical technique called aortic valve replacement that greatly increases the life expectancy of the patients. Nearly 200,000 patients undergo surgical valve replacement worldwide every year. However not all patients can undergo the surgery.

Approximately 2/3 rd of the patients do not receive the surgery due to associated risk factors and morbidity or patient refusal due to fear of lifestyle changes following surgery in elderly patients. The number is only expected to rise, considering the density of aging population.

Thanks to the promise offered by a new, less invasive, therapeutic surgical technique called percutaneous aortic valve replacement that is becoming a reality. The surgical procedure has given hope for a number of patients who cannot currently be treated with traditional surgical techniques.

The surgery has been performed successfully in a cardiac care centre in Canada either under local anaesthesia or under light sedation. Reports regarding the valve performance have been excellent and there has not been a single case of valve failure when the valve was successfully placed (80% of the cases). High mortality during follow-up has been related to non-valvular causes, mainly the evolution of life-threatening comorbidities.

Two multicentre studies have just begun enrollment in Europe (REVIVE trial) and the US (REVIVAL trial ) that will help to determine the future of this revolutionary and promising interventional cardiology procedure. If technical hurdles regarding the surgical procedure are overcome, then the option could be made more feasible in high-risk cardiac patients.
'"/>




Related medicine news :

1. Mutations in NOTCH1 cause an early developmental defect in the aortic valve
2. Award for TTK Chitra heart valve prosthesis
3. Defective heart valve causes problems
4. Mutations in NOTCH1 cause an early developmental defect in the aortic valve
5. Heart valve surgery may be replaced by new heart therapy
6. Laboratory Heart valve to study Heart diseases
7. Hemopurifier may revolutionise AIDS treatment
8. Best out of waste: Microbiological revolution!
9. Cardiac diseases develop early
10. Heart problems detected better with a Cardiac MRI
11. Cardiac events better treated with intense cholesterol-lowering regime
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... ... 2016 , ... TopConsumerReviews.com recently awarded their highest five-star rating to Best Buy ... in the United States and Canada wear eyeglasses. Once considered to be a purely ... make a fashion statement. Even celebrities use glasses as a way of creating an ...
(Date:6/26/2016)... ... ... Kasmer, a legally blind and certified personal trainer is helping to develop a weight loss ... plans to fix the two major problems leading the fitness industry today:, ... , They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... California (PRWEB) , ... June 25, 2016 , ... "With ... fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... customizable and all within Final Cut Pro X . Simply select a ProHand ...
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... June 24, 2016 , ... The ... in Dallas that it will receive two significant new grants to support its ... PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists for ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
(Date:6/23/2016)... -- MedSource announced today that it has selected Datatrial,s ... choice.  This latest decision demonstrates MedSource,s commitment to ... by offering a state-of-the-art electronic data capture (EDC) ... the EDC platform of choice in exchange for ... long been a preferred EDC platform by our ...
(Date:6/23/2016)... -- Research and Markets has announced the ... (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, ... Global Forecast to 2021" report to their offering. ... pharmaceutical excipients market is projected to reach USD 8.1 ... the forecast period 2016 to 2021. ...
Breaking Medicine Technology: